AAAAAA
Results:
1-12
|
Results: 12
Authors:
LEE SC
BRUMMET ME
WOODWORTH T
LEIFERMAN KM
GILMAN S
GLADUE R
SCHLEIMER RP
BECK LA
Citation: Sc. Lee et al., CUTANEOUS INJECTION OF HUMAN-SUBJECTS WITH MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA) CAUSES SIGNIFICANT LEUKOCYTE RECRUITMENT, Journal of allergy and clinical immunology, 101(1), 1998, pp. 821-821
Authors:
COHEN R
JAFFE ES
STETLERSTEVENSON MA
SAUSVILLE EA
DENIGRIS EC
WOODWORTH T
FOSS FM
Citation: R. Cohen et al., BILATERAL ADRENAL HEMORRHAGE AND ADRENAL INSUFFICIENCY IN A PATIENT WITH LYMPHOMATOUS ADRENAL INFILTRATION FOLLOWING ADMINISTRATION OF A FUSION TOXIN (DAB(486)INTERLEUKIN-2), Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 229-233
Authors:
VANDERSPEK J
COSENZA L
WOODWORTH T
NICHOLS JC
MURPHY JR
Citation: J. Vanderspek et al., DIPHTHERIA TOXIN-RELATED CYTOKINE FUSION PROTEINS - ELONGATION-FACTOR-2 AS A TARGET FOR THE TREATMENT OF NEOPLASTIC DISEASE, Molecular and cellular biochemistry, 138(1-2), 1994, pp. 151-156
Authors:
GOTTLIEB S
JOHNSON R
GILLEAUDEAU P
WOODWORTH T
NYLEN P
GOTTLIEB A
KRUEGER J
Citation: S. Gottlieb et al., A SPECIFIC LYMPHOCYTE TOXIN (DA(389)IL-2) REVERSES EPIDERMAL KERATINOCYTE ACTIVATION IN PSORIASIS - IMPROVEMENT CORRELATES WITH ELIMINATIONOF INTRAEPIDERMAL CD8+ LYMPHOCYTES, Journal of investigative dermatology, 102(4), 1994, pp. 531-531
Authors:
FOSS FM
BORKOWSKI TA
GILLIOM M
STETLERSTEVENSON M
JAFFE ES
FIGG WD
TOMPKINS A
BASTIAN A
NYLEN P
WOODWORTH T
UDEY MC
SAUSVILLE EA
Citation: Fm. Foss et al., CHIMERIC FUSION PROTEIN TOXIN DAB(486) IL-2 IN ADVANCED MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME - CORRELATION OF ACTIVITY AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN A PHASE-II STUDY, Blood, 84(6), 1994, pp. 1765-1774
Authors:
KUZEL TM
ROSEN ST
GORDON LI
WINTER J
SAMUELSON E
KAUL K
ROENIGK HH
NYLEN P
WOODWORTH T
Citation: Tm. Kuzel et al., PHASE-I TRIAL OF THE DIPHTHERIA TOXIN INTERLEUKIN-2 FUSION PROTEIN DAB(486)IL-2 - EFFICACY IN MYCOSIS-FUNGOIDES AND OTHER NON-HODGKINS-LYMPHOMAS/, Leukemia & lymphoma, 11(5-6), 1993, pp. 369-377
Authors:
HESKETH P
CAGUIOA P
KOH H
DEWEY H
FACADA A
MCCAFFREY R
PARKER K
NYLEN P
WOODWORTH T
Citation: P. Hesketh et al., CLINICAL ACTIVITY OF A CYTOTOXIC FUSION PROTEIN IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1682-1690
PHASE I II TRIAL OF DAB486-IL-2 FUSION TOXIN IN PATIENTS WITH RECENT-ONSET TYPE-I DIABETES-MELLITUS/
Authors:
TIMSIT J
ASSAN R
MOGENET A
DEBUSSCHE X
KALOUSTIAN E
ATTALI JR
CHANSON P
CHATENOUD L
WOODWORTH T
BACH JF
BOITARD C
Citation: J. Timsit et al., PHASE I II TRIAL OF DAB486-IL-2 FUSION TOXIN IN PATIENTS WITH RECENT-ONSET TYPE-I DIABETES-MELLITUS/, Diabetes, 42, 1993, pp. 205-205
Authors:
LEMAISTRE CF
CRAIG FE
MENEGHETTI C
MCMULLIN B
PARKER K
REUBEN J
BOLDT DH
ROSENBLUM M
WOODWORTH T
Citation: Cf. Lemaistre et al., PHASE-I TRIAL OF A 90-MINUTE INFUSION OF THE FUSION TOXIN DAB486IL-2 IN HEMATOLOGICAL CANCERS, Cancer research, 53(17), 1993, pp. 3930-3934
Authors:
LEMAISTRE CF
KUZEL T
FOSS F
HESKETH P
SALEH M
PLATANIAS L
SCHWARTZ G
CRAIG F
TOLSON K
WOODWORTH T
Citation: Cf. Lemaistre et al., DAB389IL-2 IS WELL TOLERATED AT DOSES INDUCING RESPONSE IN IL-2 RECEPTOR-EXPRESSING LYMPHOMAS, Blood, 82(10), 1993, pp. 10000137-10000137
Authors:
FURST DE
PARKER K
WOODWORTH T
Citation: De. Furst et al., VARIATIONS IN SWOLLEN JOINT COUNTS DURING DMARD WASH-OUTS AND PLACEBO-TREATMENT IN PATIENTS ENTERING DAB-IL-2 TRIALS, Arthritis and rheumatism, 36(9), 1993, pp. 190000179-190000179
Authors:
ALARCON GS
JACKSON B
PARKHILL TR
MORELAND LW
WOODWORTH T
KOOPMAN WJ
Citation: Gs. Alarcon et al., PERFORMANCE OF THE MAASTRICH CRITERIA COMPARED WITH CLINICAL-RESPONSECRITERIA USED IN THE PHASE-II DAB486 IL-2 FUSION TOXIN TRIAL IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 36(9), 1993, pp. 190000179-190000179
Risultati:
1-12
|